SOD1 and ischemia: Although Cu,Zn-superoxide dismutase (SOD1) activity significantly increased (1.318-fold) 24 h after ischemia/reperfusion, compared with the control, in the vehicle-treated group, there was a sharp drop 72 h after ischemia/reperfusion and SOD1 activity was lower the control group.